Portal de Periódicos da CAPES

Reduction in Pulmonary Vascular Resistance with Long-Term Epoprostenol (Prostacyclin) Therapy in Primary Pulmonary Hypertension

1998; Massachusetts Medical Society; Volume: 338; Issue: 5 Linguagem: Inglês

10.1056/nejm199801293380501

1533-4406

Vallerie V. McLaughlin, Diane Genthner, Maureen M. Panella, Stuart Rich,

Cardiovascular Issues in Pregnancy

Primary (idiopathic) pulmonary hypertension is a progressive, fatal disease. Conventional therapy with anticoagulant and vasodilator drugs may improve symptoms and survival among selected patients, but there is no evidence that the disease can be reversed.